Repository logo
 
Publication

Identification of risks and benefits associated to the consumption of raw milk: the first step of a risk-benefit assessment

dc.contributor.authorAssunção, Ricardo
dc.contributor.authorPires, Sara
dc.contributor.authorNauta, Marten
dc.date.accessioned2020-05-18T13:03:44Z
dc.date.available2020-05-18T13:03:44Z
dc.date.issued2019-09
dc.description.abstractMilk is a highly nutritious food. Due to consumers’ perception that raw milk (RM) is a better source of nutrients and other active components there is currently considerable debate on the potential health benefits of consumption of RM compared to pasteurized milk (PM). Current trends advocating for “consuming natural” and “purchasing locally” have contributed to the increased popularity of RM in some countries (e.g. Italy, Estonia and the US). Claimed health benefits are e.g. “higher nutritional value”, especially in terms of vitamins’ contents, “beneficial microflora” as probiotic bacteria, and “allergy prevention”. However, several human pathogens can be present in RM and have been identified as the cause of several foodborne outbreaks. Consequently, this new trend encourages a proper assessment of the associated risks and benefits through a quantitative risk-benefit assessment (RBA). Traditionally, RBA considers as a first step the identification of the risks and the benefits posed by the considered food product, gathering scientific evidence for the inclusion or exclusion of each food component. This study aimed to identify the risks and the benefits associated to the consumption of RM when compared to PM. Through literature search, the nutritional, toxicological and microbiological food components that could be present in RM and PM were identified. For each identified food component, scientific evidence were analysed to support the decision about the inclusion or exclusion of each food component. Microbiological pathogens (Listeria monocytogenes, Salmonella spp., Campylobacter jejuni and Shiga toxin-producing Escherichia coli), probiotic bacteria (Lactobacillus spp.) and nutritional components (vitamins B2 and A) were identified, as well as the potential impact of RM in the reduction of the allergies’ prevalence. Since it is not expected that heat-treatment could affect the occurrence of chemical toxic compounds in milk, no toxicological components were identified in the assessment. We identified the main components that should be considered in RBA of RM consumption. Such a quantitative RBA will contribute to inform the consumers about the magnitude of the risk and the expected health impact.pt_PT
dc.description.sponsorshipthis study was performed under EU-FORA – The European Food Risk Assessment Fellowship, funded by EFSA.pt_PT
dc.description.versionN/Apt_PT
dc.identifier.urihttp://hdl.handle.net/10400.18/6679
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt_PT
dc.subjectSegurança Alimentarpt_PT
dc.subjectToxicologiapt_PT
dc.subjectAvaliação do Riscopt_PT
dc.subjectSaúde Humanapt_PT
dc.subjectLeitept_PT
dc.subjectMilkpt_PT
dc.titleIdentification of risks and benefits associated to the consumption of raw milk: the first step of a risk-benefit assessmentpt_PT
dc.typeconference object
dspace.entity.typePublication
oaire.citation.conferencePlaceAveiro, Portugalpt_PT
oaire.citation.title3rd International Conference on Food Contaminants (ICFC 2019): Challenges in Risk Assessment, 26-27 September 2019pt_PT
rcaap.rightsclosedAccesspt_PT
rcaap.typeconferenceObjectpt_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Poster_Identification of risks and benefits associated to the consumption of raw milk the first step of a risk-benefit assessment .pdf
Size:
510.29 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: